Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002966686 | SCV003284314 | likely benign | not provided | 2024-08-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002966687 | SCV003682387 | uncertain significance | Inborn genetic diseases | 2022-10-04 | criteria provided, single submitter | clinical testing | The c.2459G>A (p.R820K) alteration is located in exon 17 (coding exon 17) of the PPP1R12A gene. This alteration results from a G to A substitution at nucleotide position 2459, causing the arginine (R) at amino acid position 820 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Institute for Clinical Genetics, |
RCV002966686 | SCV004026240 | uncertain significance | not provided | 2023-01-09 | criteria provided, single submitter | clinical testing | PM2_SUP |